Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Ifosfamide × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 76 Osteosarcoma 29 Neuroectodermal Tumors, Primitive, Peripheral 14 Fibrosarcoma 13 Rhabdomyosarcoma 12 Neurofibrosarcoma 11 Liposarcoma 11 Leiomyosarcoma 11 Histiocytoma, Malignant Fibrous 11 Sarcoma, Synovial 10 Hemangiosarcoma 10 Sarcoma, Ewing 8 Ovarian Neoplasms 8 Malignant mesenchymal tumor 7 Kidney Neoplasms 6 Hemangiopericytoma, Malignant 6 Dendritic Cell Sarcoma, Interdigitating 6 Wilms Tumor 5 Sarcoma, Alveolar Soft Part 5 Neoplasms 5 Carcinoma, Renal Cell 5 Neuroblastoma 4 Medulloblastoma 4 Lymphoma, Large B-Cell, Diffuse 4 Chondrosarcoma, Extraskeletal Myxoid 4 Chondrosarcoma 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Testicular Neoplasms 3 Sarcoma, Clear Cell 3

Interventions

Diathermy 2 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Melphalan 1 Ifosfamide 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡